Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications.
about
Model-specific selection of molecular targets for heart failure gene therapyWhat can we learn about treating heart failure from the heart's response to acute exercise? Focus on the coronary microcirculationLipid emulsion combined with epinephrine and vasopressin does not improve survival in a swine model of bupivacaine-induced cardiac arrest.Bovine model of doxorubicin-induced cardiomyopathyResponses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheepMMPs as therapeutic targets--still a viable option?Model systems for cardiovascular regenerative biology.Translation of Methodology Used In Human Myocardial Imaging to a Sheep Model of Acute Myocardial InfarctionBasis for the preferential activation of cardiac sympathetic nerve activity in heart failure.Specific control of sympathetic nerve activity to the mammalian heart and kidney.Role of heart rate as a marker and mediator of poor outcome for patients with heart failure.Percutaneous methods of vector delivery in preclinical models.Gene deletion screen for cardiomyopathy in adult Drosophila identifies a new notch ligand.Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy.Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure.Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application.Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine.Effects of Ganoderma Lucidum shell-broken spore on oxidative stress of the rabbit urinary bladder using an in vivo model of ischemia/reperfusion.
P2860
Q26823061-D594BDD5-2805-43EF-BF94-601953BCB0BAQ28083350-F4A3A2F0-DAAD-48FA-826A-D16CFCA1DDC5Q34240983-65DA98E0-E212-4FCE-8446-D6AB1E43A48AQ34479363-5E28390B-6756-4ADD-84C3-49DA894CE046Q36877606-AD5D9179-2C3D-4B37-9BBC-05592DFA1FE6Q36908023-81EB8CF7-7BE8-46E0-BB98-C8CE3E74D90BQ36933190-17D214D4-05C6-4816-AAAB-573864715769Q37052256-62881B4B-711D-4767-9AAA-93790B48FD1CQ37070506-BD56533F-6E2E-46BF-8F3D-90D11F1BF620Q37555769-51BB5873-A437-453E-8DC5-A55B77374ECAQ37986643-CE5FCAA8-6CC9-49AC-9386-90E7D8D5567FQ37993680-31B4A8F5-3587-4FEC-B29F-92815B89A8A2Q39732194-16EB4942-CD7A-472E-8E57-FA375E5CEFE9Q41376683-A3D95197-E501-4E78-9D03-B138D541874CQ46650386-2E927869-27AF-4A9F-9F15-EE4BC11A5B86Q47110057-61F8F443-3A6C-4053-8276-65E88D405814Q47270959-42945750-7BA3-4348-A0EF-799F0F0F09DCQ47589212-E0940C37-69C6-478B-9D6F-AA1BABE46866Q51823887-9DFD545C-DD44-433D-905E-C7E8614F69B6
P2860
Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Large animal models of congest ...... ns into clinical applications.
@ast
Large animal models of congest ...... ns into clinical applications.
@en
type
label
Large animal models of congest ...... ns into clinical applications.
@ast
Large animal models of congest ...... ns into clinical applications.
@en
prefLabel
Large animal models of congest ...... ns into clinical applications.
@ast
Large animal models of congest ...... ns into clinical applications.
@en
P356
P1476
Large animal models of congest ...... ns into clinical applications.
@en
P2093
Francis G Spinale
William M Yarbrough
P2888
P356
10.1067/MNC.2003.16
P577
2003-01-01T00:00:00Z
P6179
1024831518